Intervention

spironolactone

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 13 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials13
Recruiting1
Common conditions16
Lead sponsors shown12
Advertisement

Clinical trials

13 shown
Efficacy of Spironolactone Combined With Antihypertensive Drugs in Patients With Primary AldosteronismNCT07137364 · 2022-05-01
RECRUITING
Spironolactone Safety in Dialysis PatientsNCT00328809 · 2013-06-30
WITHDRAWN
Patiromer in the Treatment of Hyperkalemia in Patients With Hypertension and Diabetic Nephropathy (AMETHYST-DN)NCT01371747 · 2011-06-01
COMPLETED
Evaluation of Patiromer Titration in Heart Failure Patients With Chronic Kidney DiseaseNCT01130597 · 2010-05-01
COMPLETED
The Effect of Spironolactone on Blood Pressure in Type-2 Diabetics With Resistant HypertensionNCT01062763 · 2010-03-01
COMPLETED
Spironolactone Versus Amiloride as an Add on Agent in Resistant HypertensionNCT00709137 · 2008-10-01
WITHDRAWN
Importance of Aldosterone in the Pathogenesis of Hypertensive Heart DiseaseNCT00865501 · 2008-03-01
COMPLETED
Effect of Aldosterone on Energy Starvation in Heart FailureNCT00574119 · 2007-12-01
COMPLETED
Addition of Spironolactone in Patients With Resistant Arterial HypertensionNCT00524615 · 2007-09-01
UNKNOWN
Effect of Betablocker or Aldosterone Antagonist Therapy on Patients With Liver CirrhosisNCT00332904 · 2006-08-01
UNKNOWN
Larger Dose of Spironolactone for the Treatment of Patients With Nonischemic CardiomyopathyNCT00125437 · 2005-09-01
TERMINATED
Spironolactone for Reducing Proteinuria in Diabetic NephropathyNCT00498537 · 2003-01-01
COMPLETED
Examining the Effect of Different Diuretics on Fluid Retention in Diabetics Treated With Rosiglitazone.NCT00306696 · 2002-10-01
COMPLETED

Trial status mix

COMPLETED7
UNKNOWN2
WITHDRAWN2
RECRUITING1
TERMINATED1

Phase mix

PHASE45
NA3
PHASE22
PHASE32
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.